Tom 13, Nr 4 (2016)
Nadciśnienie tętnicze
Opublikowany online: 2016-11-30
Wyświetlenia strony
301
Wyświetlenia/pobrania artykułu
436
Komentarz
Choroby Serca i Naczyń 2016;13(4):251-252.
Streszczenie
Brak
Referencje
- Polskiego pacjenta portret własny — raport o przestrzeganiu zaleceń terapeutycznych przez polskich pacjentów. Fundacja na rzecz Wspierania Rozwoju Polskiej Farmacji i Medycyny Warszawa, 2015.
- Wang TD, Chen YH, Huang CH, et al. Bidirectional adherence changes and associated factors in patients switched from free combinations to equivalent single-pill combinations of antihypertensive drugs. Hypertension. 2014; 63(5): 958–967.
- Dahlöf B, Sever PS, Poulter NR, et al. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005; 366(9489): 895–906.
- Sever PS, Dahlöf B, Poulter NR, et al. ASCOT Investigators, ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003; 361(9364): 1149–1158.
- Sever P, Dahlöf B, Poulter N, et al. ASCOT Steering Committee Members. Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J. 2006; 27(24): 2982–2988.
